Is Citizens, Inc. (Austin, Texas) overvalued or undervalued?

As of 10 September 2025, the valuation grade for Citizens, Inc. has moved from expensive to very expensive, indicating a significant increase in perceived valuation. The company appears to be overvalued based on its current metrics, particularly with a P/E ratio of 23, which is notably higher than its peers, such as Abacus Life, Inc. with a P/E of 164.30 and eHealth, Inc. at 4.03. Additionally, the EV to EBITDA ratio stands at an exceptionally high 129.70, further supporting the overvaluation assessment.
In comparison to the S&P 500, Citizens, Inc. has shown strong short-term performance, with a year-to-date return of 39.40% compared to the index's 12.22%. However, its long-term returns are concerning, with a 5-year return of -3.29% versus the S&P 500's 96.61%. Overall, the combination of high valuation ratios and mixed performance suggests that Citizens, Inc. is overvalued in the current market context.